D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Tesla
TSLA
|
+$765M |
| 2 |
Baidu
BIDU
|
+$627M |
| 3 |
Coca-Cola
KO
|
+$444M |
| 4 |
NVIDIA
NVDA
|
+$380M |
| 5 |
Tencent Music
TME
|
+$344M |
Top Sells
| 1 |
Amazon
AMZN
|
+$957M |
| 2 |
Wells Fargo
WFC
|
+$743M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$604M |
| 4 |
GameStop
GME
|
+$532M |
| 5 |
DuPont de Nemours
DD
|
+$420M |
Sector Composition
| 1 | Technology | 20.29% |
| 2 | Consumer Discretionary | 13.32% |
| 3 | Healthcare | 10.88% |
| 4 | Communication Services | 10.66% |
| 5 | Financials | 8.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2301
Caesars Entertainment
CZR
$5.33B
| $586K | ﹤0.01% |
6,700
+3,800
| +131% | +$332K |
|
2302
Oaktree Specialty Lending
OCSL
$1.21B
| $585K | ﹤0.01% |
31,478
-70,346
| -69% | -$1.31M |
|
|
HPX
2303
DELISTED
HPX Corp.
HPX
| $585K | ﹤0.01% |
+59,572
| New | +$585K |
|
2304
Ituran Location and Control
ITRN
$678M
| $583K | ﹤0.01% |
27,462
-42,479
| -61% | -$902K |
|
2305
908 Devices
MASS
$206M
| $581K | ﹤0.01% |
+11,971
| New | +$581K |
|
2306
XPeng
XPEV
$19.1B
| $581K | ﹤0.01% |
15,913
-2,660,421
| -99% | -$97.1M |
|
2307
CorVel
CRVL
$4.39B
| $578K | ﹤0.01% |
16,920
-3,327
| -16% | -$114K |
|
2308
First Internet Bancorp
INBK
$209M
| $578K | ﹤0.01% |
16,420
+1,262
| +8% | +$44.4K |
|
2309
Orion Group Holdings
ORN
$295M
| $574K | ﹤0.01% |
94,607
-104,233
| -52% | -$632K |
|
2310
Saratoga Investment
SAR
$391M
| $573K | ﹤0.01% |
22,638
-21,925
| -49% | -$555K |
|
2311
Luxfer Holdings
LXFR
$358M
| $572K | ﹤0.01% |
26,861
-3,534
| -12% | -$75.3K |
|
2312
Assertio
ASRT
$77.5M
| $571K | ﹤0.01% |
209,323
-371,033
| -64% | -$1.01M |
|
2313
Fulgent Genetics
FLGT
$667M
| $571K | ﹤0.01% |
+5,905
| New | +$571K |
|
|
FLXN
2314
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $570K | ﹤0.01% |
63,641
-14,773
| -19% | -$132K |
|
2315
Kymera Therapeutics
KYMR
$3.11B
| $569K | ﹤0.01% |
14,645
-16,947
| -54% | -$658K |
|
2316
Unitil
UTL
$812M
| $564K | ﹤0.01% |
+12,334
| New | +$564K |
|
|
PMT
2317
PennyMac Mortgage Investment
PMT
$1.08B
| $561K | ﹤0.01% |
28,652
-1,447,169
| -98% | -$28.3M |
|
|
DSAC
2318
DELISTED
Duddell Street Acquisition Corp. Class A Ordinary Shares
DSAC
| $561K | ﹤0.01% |
+57,392
| New | +$561K |
|
|
ARNA
2319
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $561K | ﹤0.01% |
+8,091
| New | +$561K |
|
2320
BlackRock Corporate High Yield Fund
HYT
$1.53B
| $558K | ﹤0.01% |
47,500
| – | – |
|
|
NESR
2321
National Energy Services Reunited Corp. Ordinary Shares
NESR
$1B
| $556K | ﹤0.01% |
+44,937
| New | +$556K |
|
|
OCA
2322
DELISTED
Omnichannel Acquisition Corp.
OCA
| $556K | ﹤0.01% |
+57,012
| New | +$556K |
|
2323
Trex
TREX
$6.43B
| $553K | ﹤0.01% |
6,040
+3,163
| +110% | +$290K |
|
|
AAT
2324
American Assets Trust
AAT
$1.25B
| $552K | ﹤0.01% |
17,001
-140,146
| -89% | -$4.55M |
|
2325
ScottsMiracle-Gro
SMG
$3.5B
| $552K | ﹤0.01% |
+2,252
| New | +$552K |
|